These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30579123)

  • 61. Anticancer application of ferrocene appended configuration-regulated half-sandwich iridium(III) pyridine complexes.
    Wang Z; Lv Z; Liu X; Wu Y; Chang J; Dong R; Li C; Yuan XA; Liu Z
    J Inorg Biochem; 2022 Dec; 237():112010. PubMed ID: 36152469
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
    Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
    Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
    Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
    ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.
    Ludwig G; Ranđelović I; Maksimović-Ivanić D; Mijatović S; Bulatović MZ; Miljković D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    ChemMedChem; 2014 Jul; 9(7):1586-93. PubMed ID: 24470190
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Potent half-sandwich Ru(Ⅱ) N^N (aryl-BIAN) complexes: Lysosome-mediated apoptosis, in vitro and in vivo anticancer activities.
    Xu Z; Huang J; Kong D; Yang Y; Guo L; Jia X; Zhong G; Liu Z
    Eur J Med Chem; 2020 Dec; 207():112763. PubMed ID: 32882612
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
    Du J; Kang Y; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Wang Y; Luo Q; Wu K; Wang F
    Inorg Chem; 2016 May; 55(9):4595-605. PubMed ID: 27093574
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis, structure, and antiproliferative activity of ruthenium(II) arene complexes with N,O-chelating pyrazolone-based β-ketoamine ligands.
    Pettinari R; Marchetti F; Pettinari C; Petrini A; Scopelliti R; Clavel CM; Dyson PJ
    Inorg Chem; 2014 Dec; 53(24):13105-11. PubMed ID: 25412203
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In Vitro and In Vivo Antitumor Assay of Mitochondrially Targeted Fluorescent Half-Sandwich Iridium(III) Pyridine Complexes.
    Wang L; Liu X; Wu Y; He X; Guo X; Gao W; Tan L; Yuan XA; Liu J; Liu Z
    Inorg Chem; 2023 Feb; 62(8):3395-3408. PubMed ID: 36763897
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structurally Strained Half-Sandwich Iridium(III) Complexes As Highly Potent Anticancer Agents.
    Carrasco AC; Rodríguez-Fanjul V; Habtemariam A; Pizarro AM
    J Med Chem; 2020 Apr; 63(8):4005-4021. PubMed ID: 32207946
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Iridium(iii) complexes as mitochondrial topoisomerase inhibitors against cisplatin-resistant cancer cells.
    He L; Xiong K; Wang L; Guan R; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2021 Aug; 57(67):8308-8311. PubMed ID: 34319315
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
    Novak MS; Büchel GE; Keppler BK; Jakupec MA
    J Biol Inorg Chem; 2016 Jun; 21(3):347-56. PubMed ID: 26961253
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Design, synthesis and anticancer evaluation of novel half-sandwich Ru(II) complexes bearing pyrazalone moiety: Apoptosis inducers based on mitochondrial dysfunction and G0/G1 arrest.
    Huang Y; Huang S; Wei W; Wu Y; Jia L; Du Y; Luo P; Pan W
    J Inorg Biochem; 2024 Jan; 250():112421. PubMed ID: 37922609
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex.
    Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W
    J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New Organometallic Tetraphenylethylene⋅Iridium(III) Complexes with Antineoplastic Activity.
    Liu X; He X; Zhang X; Wang Y; Liu J; Hao X; Zhang Y; Yuan XA; Tian L; Liu Z
    Chembiochem; 2019 Nov; 20(21):2767-2776. PubMed ID: 31119850
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and structural characterization of binuclear half-sandwich iridium, rhodium and ruthenium complexes containing 4,4'-dipyridyldisulfide (4DPDS) ligands.
    Han YF; Li H; Fei Y; Lin YJ; Zhang WZ; Jin GX
    Dalton Trans; 2010 Aug; 39(30):7119-24. PubMed ID: 20593103
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Comparative Analysis of the In Vitro Anticancer Activity of Iridium(III) {η
    De Palo A; Draca D; Murrali MG; Zacchini S; Pampaloni G; Mijatovic S; Maksimovic-Ivanic D; Marchetti F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299041
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo.
    He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The anticancer application of half-sandwich iridium(III) ferrocene-thiosemicarbazide Schiff base complexes.
    Liu X; Lv A; Zhang P; Chang J; Dong R; Liu M; Liu J; Huang X; Yuan XA; Liu Z
    Dalton Trans; 2024 Jan; 53(2):552-563. PubMed ID: 38054240
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis, characterization and biological activity of new cyclometallated platinum(iv) iodido complexes.
    Bauer E; Domingo X; Balcells C; Polat IH; Crespo M; Quirante J; Badía J; Baldomà L; Font-Bardia M; Cascante M
    Dalton Trans; 2017 Nov; 46(43):14973-14987. PubMed ID: 29048088
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action.
    Novohradsky V; Yellol J; Stuchlikova O; Santana MD; Kostrhunova H; Yellol G; Kasparkova J; Bautista D; Ruiz J; Brabec V
    Chemistry; 2017 Nov; 23(61):15294-15299. PubMed ID: 28922506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.